Hainan Poly Pharm Co Ltd (300630) — Capital Reinvestment Ratio

Latest as of June 2023: 4.22x

Hainan Poly Pharm Co Ltd (300630) has a Capital Reinvestment Ratio of 4.22x as of June 2023, meaning it reinvests 4% of its operating cash flow (CN¥44.82 Million) in capital expenditures (CN¥189.19 Million). See Hainan Poly Pharm Co Ltd (300630) balance sheet quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

4.22x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥44.82 Million
CNY

Capital Expenditures

CN¥189.19 Million
CNY

Data as of

Jun 2023
Most recent filing

Hainan Poly Pharm Co Ltd Capital Reinvestment Ratio (2016–2023)

This chart tracks Hainan Poly Pharm Co Ltd's Capital Reinvestment Ratio across 8 annual periods. Check Hainan Poly Pharm Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Hainan Poly Pharm Co Ltd (2016–2023)

Year-by-year Capital Reinvestment Ratio for Hainan Poly Pharm Co Ltd from 2016 to 2023. For live market cap and broader valuation context, see Hainan Poly Pharm Co Ltd market cap and net worth.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2023 4.86x CN¥112.72 Million CN¥548.15 Million ▲ +150.6%
2022 1.94x CN¥534.29 Million CN¥1.04 Billion ▼ -62.1%
2021 5.12x CN¥157.03 Million CN¥803.78 Million ▲ +103.2%
2020 2.52x CN¥332.08 Million CN¥836.54 Million ▲ +34.8%
2019 1.87x CN¥215.37 Million CN¥402.51 Million ▼ -29.7%
2018 2.66x CN¥94.79 Million CN¥251.99 Million ▲ +42.8%
2017 1.86x CN¥93.79 Million CN¥174.58 Million ▲ +13.3%
2016 1.64x CN¥55.53 Million CN¥91.19 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow